Company / EPS (Diluted)
iRhythm Holdings, Inc. EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$4.04
FY2025
5-year range
-$4.04 / -$1.58
FY2021-FY2025
Trend
-4.1%
vs FY2024
Sector context
#146 of 159
Health Care
What the data says
Among 159 Health Care companies, iRhythm Holdings, Inc. is in the bottom 8% for eps (diluted). EPS (Diluted) has declined for 3 consecutive years, from $-1.58 in FY2022 to $-4.04 in FY2025.
Based on SEC 10-K filings.
-4.04 in FY2025.
Declined from $-3.46 to $-4.04 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 8% in Health CareTop 92% of 159This company -$4.04 Sector average $1.66
▼
-344.1% below sector average
Key checks
Key Insights
- iRhythm Holdings, Inc.'s eps (diluted) has declined for 3 consecutive years.
- In FY2025, eps (diluted) decreased 4.1% year-over-year.
- Ranks #146 out of 159 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.35 (distress zone, below 1.8 threshold)
- Negative profit margin: -19.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$4.04 | -4.1% |
| FY2024 | -$3.88 | -12.1% |
| FY2023 | -$3.46 | -119.0% |
| FY2022 | -$1.58 | +26.9% |
| FY2021 | -$2.16 | -2.4% |
| FY2020 | -$2.11 | -61.1% |
| FY2019 | -$1.31 | +66.8% |
| FY2018 | -$3.95 | +76.2% |
| FY2017 | -$16.57 | -37.5% |
| FY2016 | -$12.05 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026